Results 211 to 220 of about 27,178 (263)

Cytokines in Allergic Conjunctivitis: Unraveling Their Pathophysiological Roles. [PDF]

Life (Basel)
Chigbu DI, Karbach NJ, Abu SL, Hehar NK.
europepmc   +1 more source

Safety and efficacy of a novel 0.5% epinastine topical eyelid cream in allergic conjunctivitis: a phase 3 trial. [PDF]

Jpn J Ophthalmol
Fujishima H, Shoji J.
europepmc   +1 more source

Depletion of Thymus-Derived CD4+CD25+ T Cells Abrogates the Suppressive Effects of α-galactosylceramide Treatment on Experimental Allergic Conjunctivitis

, 2008
Atsuki Fukushima, Tamaki Sumi, Waka Ishida, Ayako Ojima, Minako Kajisako, Hisayuki Ueno, Osamu Taguchi   +6 more
openalex   +1 more source

A Randomized, Multicenter Phase 3 Clinical Trial Evaluating Intracanalicular Dexamethasone Insert for the Treatment of Allergic Conjunctivitis. [PDF]

Clin Ophthalmol
Kenyon K, McLaurin EB, Silverstein SM, Meyer JC, Anderson E, Patel RH, Gomes PJ, Reilly E, Vantipalli S, Cheung MW, Goldstein MH.   +10 more
europepmc   +1 more source

Evaluation of Novel Scoring System Named 5-5-5 Exacerbation Grading Scale for Allergic Conjunctivitis Disease

, 2009
Jun Shoji, Noriko Inada, Mitsuru Sawa
openalex   +1 more source

Polymeric Mixed Micelle-Loaded Hydrogel for the Ocular Delivery of Fexofenadine for Treating Allergic Conjunctivitis. [PDF]

Polymers (Basel)
El-Shahed SA, Hassan DH, El-Nabarawi MA, El-Setouhy DA, Abdellatif MM.   +4 more
europepmc   +1 more source

Latex allergy: a challenge for anaesthetists [PDF]

, 2006
Demaegd, J, Herregods, Luc, Soetens, F
core   +1 more source

Ophthalmic Formulations for the Treatment of Allergic Conjunctivitis and Their Effect on the Ocular Surface: A Review of Safety and Tolerability Assessments in Clinical Trials. [PDF]

J Clin Med
Suárez-Cortés T, Gonzalo A, Arana E, Guillén V, Andollo N.   +4 more
europepmc   +1 more source

TWEAK/Fn14 disrupts Th17/Treg balance and aggravates conjunctivitis by inhibiting the Nrf2/HO-1 pathway in allergic conjunctivitis mice. [PDF]

Mol Med
Yang Y, Zhang Y, Fu J, Yin X.
europepmc   +1 more source